Kobayashi Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3301100008
JPY
5,617.00
144 (2.63%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Astellas Pharma, Inc.
Kyowa Kirin Co., Ltd.
Shionogi & Co., Ltd.
Ono Pharmaceutical Co., Ltd.
Otsuka Holdings Co., Ltd.
Chugai Pharmaceutical Co., Ltd.
Daiichi Sankyo Co., Ltd.
Eisai Co., Ltd.
Kobayashi Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd.
Taisho Pharmaceutical Holdings Co., Ltd.

Why is Kobayashi Pharmaceutical Co., Ltd. ?

1
Weak Long Term Fundamental Strength with a -11.74% CAGR growth in Operating Profits over the last 5 years
2
Poor long term growth as Net Sales has grown by an annual rate of 2.30% and Operating profit at -11.74% over the last 5 years
3
The company has declared Negative results for the last 3 consecutive quarters
  • ROCE(HY) Lowest at 0.78%
  • INTEREST(Q) At JPY 6 MM has Grown at 50%
  • RAW MATERIAL COST(Y) Grown by 5.01% (YoY)
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -0.20% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Kobayashi Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Kobayashi Pharmaceutical Co., Ltd.
3.41%
-0.11
18.29%
Japan Nikkei 225
60.14%
2.04
29.37%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
2.30%
EBIT Growth (5y)
-11.74%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.32
Sales to Capital Employed (avg)
0.80
Tax Ratio
17.71%
Dividend Payout Ratio
211.46%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.52%
ROE (avg)
10.01%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
2.02
EV to EBIT
25.94
EV to EBITDA
15.80
EV to Capital Employed
2.47
EV to Sales
2.14
PEG Ratio
2.73
Dividend Yield
NA
ROCE (Latest)
9.53%
ROE (Latest)
9.53%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
DIVIDEND PAYOUT RATIO(Y)

Highest at 3,345.23%

DEBTORS TURNOVER RATIO(HY)

Highest at 5 times

DIVIDEND PER SHARE(HY)

Highest at JPY 5

-25What is not working for the Company
ROCE(HY)

Lowest at 0.78%

INTEREST(Q)

At JPY 6 MM has Grown at 50%

RAW MATERIAL COST(Y)

Grown by 5.01% (YoY

CASH AND EQV(HY)

Lowest at JPY 122,358 MM

DEBT-EQUITY RATIO (HY)

Highest at -27 %

OPERATING PROFIT(Q)

Lowest at JPY 3,319 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 8.95 %

PRE-TAX PROFIT(Q)

Lowest at JPY 1,235 MM

NET PROFIT(Q)

Lowest at JPY 257.72 MM

Here's what is working for Kobayashi Pharmaceutical Co., Ltd.

Debtors Turnover Ratio
Highest at 5 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Dividend per share
Highest at JPY 5
in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (JPY)

Dividend Payout Ratio
Highest at 3,345.23%
in the last five years
MOJO Watch
Company is distributing higher proportion of profits generated as dividend

DPR (%)

Depreciation
Highest at JPY 2,508 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (JPY MM)

Here's what is not working for Kobayashi Pharmaceutical Co., Ltd.

Pre-Tax Profit
At JPY 1,235 MM has Fallen at -74.87%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (JPY MM)

Net Profit
At JPY 257.72 MM has Fallen at -91.48%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (JPY MM)

Interest
At JPY 6 MM has Grown at 50%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Operating Profit
Lowest at JPY 3,319 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (JPY MM)

Operating Profit Margin
Lowest at 8.95 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at JPY 1,235 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (JPY MM)

Net Profit
Lowest at JPY 257.72 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (JPY MM)

Cash and Eqv
Lowest at JPY 122,358 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio
Highest at -27 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost
Grown by 5.01% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Non Operating Income
Highest at JPY 0.88 MM
in the last five periods
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating income